메뉴 건너뛰기




Volumn 5, Issue 1, 2017, Pages 61-71

The diagnosis of idiopathic pulmonary fibrosis: current and future approaches

Author keywords

[No Author keywords available]

Indexed keywords

NINTEDANIB; PIRFENIDONE;

EID: 85006319411     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30325-3     Document Type: Review
Times cited : (84)

References (93)
  • 1
    • 84938125365 scopus 로고    scopus 로고
    • An official ATS/ERS/JRS/ALAT Clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline
    • 1 Raghu, G, Rochwerg, B, Zhang, Y, et al. An official ATS/ERS/JRS/ALAT Clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 192 (2015), e3–19.
    • (2015) Am J Respir Crit Care Med , vol.192 , pp. e3-19
    • Raghu, G.1    Rochwerg, B.2    Zhang, Y.3
  • 2
    • 84861394764 scopus 로고    scopus 로고
    • Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
    • 2 Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu, G, Anstrom, KJ, King, TE Jr, Lasky, JA, Martinez, FJ, Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366 (2012), 1968–1977.
    • (2012) N Engl J Med , vol.366 , pp. 1968-1977
    • Raghu, G.1    Anstrom, K.J.2    King, T.E.3    Lasky, J.A.4    Martinez, F.J.5
  • 4
    • 84965062194 scopus 로고    scopus 로고
    • Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
    • 4 Behr, J, Bendstrup, E, Crestani, B, et al. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med 4 (2016), 445–453.
    • (2016) Lancet Respir Med , vol.4 , pp. 445-453
    • Behr, J.1    Bendstrup, E.2    Crestani, B.3
  • 5
    • 84964057055 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient
    • 5 Jones, MG, Walsh, SLF, Jones, KD, Richeldi, L, Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient. Eur Respir J 47 (2016), 1057–1059.
    • (2016) Eur Respir J , vol.47 , pp. 1057-1059
    • Jones, M.G.1    Walsh, S.L.F.2    Jones, K.D.3    Richeldi, L.4
  • 6
    • 84981225532 scopus 로고    scopus 로고
    • Counterpoint: should all patients with idiopathic pulmonary fibrosis, even those with more than moderate impairment, be treated with nintedanib or pirfenidone? No
    • 6 Brown, KK, Counterpoint: should all patients with idiopathic pulmonary fibrosis, even those with more than moderate impairment, be treated with nintedanib or pirfenidone? No. Chest 150 (2016), 276–278.
    • (2016) Chest , vol.150 , pp. 276-278
    • Brown, K.K.1
  • 7
    • 84988884607 scopus 로고    scopus 로고
    • Precision medicine: the new frontier in idiopathic pulmonary fibrosis
    • 7 Brownell, R, Kaminski, N, Woodruff, PG, et al. Precision medicine: the new frontier in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193 (2016), 1213–1218.
    • (2016) Am J Respir Crit Care Med , vol.193 , pp. 1213-1218
    • Brownell, R.1    Kaminski, N.2    Woodruff, P.G.3
  • 8
    • 84959251562 scopus 로고    scopus 로고
    • Novel drug targets for idiopathic pulmonary fibrosis
    • published online Feb 26.
    • 8 Sgalla, G, Cocconcelli, E, Tonelli, R, Richeldi, L, Novel drug targets for idiopathic pulmonary fibrosis. Expert Rev Respir Med, 2016, 10.1586/17476348.2016.1152186 published online Feb 26.
    • (2016) Expert Rev Respir Med
    • Sgalla, G.1    Cocconcelli, E.2    Tonelli, R.3    Richeldi, L.4
  • 10
    • 84901022861 scopus 로고    scopus 로고
    • Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model
    • 10 Selman, M, Pardo, A, Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med 189 (2014), 1161–1172.
    • (2014) Am J Respir Crit Care Med , vol.189 , pp. 1161-1172
    • Selman, M.1    Pardo, A.2
  • 11
    • 77953077453 scopus 로고    scopus 로고
    • Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis
    • 11 Fell, CD, Martinez, FJ, Liu, LX, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 181 (2010), 832–837.
    • (2010) Am J Respir Crit Care Med , vol.181 , pp. 832-837
    • Fell, C.D.1    Martinez, F.J.2    Liu, L.X.3
  • 12
    • 84984807297 scopus 로고    scopus 로고
    • Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis of ILD patients undergoing lung tissue sampling
    • 12 Salisbury, ML, Xia, M, Murray, S, et al. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis of ILD patients undergoing lung tissue sampling. Respir Med 118 (2016), 88–95.
    • (2016) Respir Med , vol.118 , pp. 88-95
    • Salisbury, M.L.1    Xia, M.2    Murray, S.3
  • 13
    • 37349123498 scopus 로고    scopus 로고
    • Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT
    • 13 Silva, CI, Muller, NL, Lynch, DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 246 (2008), 288–297.
    • (2008) Radiology , vol.246 , pp. 288-297
    • Silva, C.I.1    Muller, N.L.2    Lynch, D.A.3
  • 14
    • 73349104430 scopus 로고    scopus 로고
    • Pathologic patterns and survival in chronic hypersensitivity pneumonitis
    • 14 Churg, A, Sin, DD, Everett, D, Brown, K, Cool, C, Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 33 (2009), 1765–1770.
    • (2009) Am J Surg Pathol , vol.33 , pp. 1765-1770
    • Churg, A.1    Sin, D.D.2    Everett, D.3    Brown, K.4    Cool, C.5
  • 15
    • 84887051071 scopus 로고    scopus 로고
    • Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study
    • 15 Morell, F, Villar, A, Montero, MA, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med 1 (2013), 685–694.
    • (2013) Lancet Respir Med , vol.1 , pp. 685-694
    • Morell, F.1    Villar, A.2    Montero, M.A.3
  • 16
    • 84942925433 scopus 로고    scopus 로고
    • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
    • 16 Fischer, A, Antoniou, KM, Brown, KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46 (2015), 976–987.
    • (2015) Eur Respir J , vol.46 , pp. 976-987
    • Fischer, A.1    Antoniou, K.M.2    Brown, K.K.3
  • 17
    • 84907333644 scopus 로고    scopus 로고
    • Smoking-related idiopathic interstitial pneumonia
    • 17 Flaherty, KR, Fell, C, Aubry, MC, et al. Smoking-related idiopathic interstitial pneumonia. Eur Respir J 44 (2014), 594–602.
    • (2014) Eur Respir J , vol.44 , pp. 594-602
    • Flaherty, K.R.1    Fell, C.2    Aubry, M.C.3
  • 18
    • 84966474593 scopus 로고    scopus 로고
    • Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case cohort study
    • 18 Walsh, SLF, Wells, AU, Desai, SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case cohort study. Lancet Respir Med 4 (2016), 557–565.
    • (2016) Lancet Respir Med , vol.4 , pp. 557-565
    • Walsh, S.L.F.1    Wells, A.U.2    Desai, S.R.3
  • 19
    • 84971275439 scopus 로고    scopus 로고
    • Hypersensitivity pneumonitis: challenges in diagnosis and management, avoiding surgical lung biopsy
    • 19 Morell, F, Villar, A, Ojanguren, I, Munoz, X, Cruz, MJ, Hypersensitivity pneumonitis: challenges in diagnosis and management, avoiding surgical lung biopsy. Semin Respir Crit Care Med 37 (2016), 395–405.
    • (2016) Semin Respir Crit Care Med , vol.37 , pp. 395-405
    • Morell, F.1    Villar, A.2    Ojanguren, I.3    Munoz, X.4    Cruz, M.J.5
  • 20
    • 79952717349 scopus 로고    scopus 로고
    • An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
    • 20 Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 (2011), 788–824.
    • (2011) Am J Respir Crit Care Med , vol.183 , pp. 788-824
    • Raghu, G.1    Collard, H.R.2    Egan, J.J.3
  • 21
    • 84867094057 scopus 로고    scopus 로고
    • Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study
    • 21 Nielsen, SF, Bojesen, SE, Schnohr, P, Nordestgaard, BG, Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ, 345, 2012, e5244.
    • (2012) BMJ , vol.345 , pp. e5244
    • Nielsen, S.F.1    Bojesen, S.E.2    Schnohr, P.3    Nordestgaard, B.G.4
  • 23
    • 0025364239 scopus 로고
    • Autoantibodies of systemic rheumatic diseases in the healthy elderly
    • 23 Ruffatti, A, Rossi, L, Calligaro, A, et al. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology 36 (1990), 104–111.
    • (1990) Gerontology , vol.36 , pp. 104-111
    • Ruffatti, A.1    Rossi, L.2    Calligaro, A.3
  • 24
    • 84872107180 scopus 로고    scopus 로고
    • Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis
    • 24 Lee, JS, Kim, EJ, Lynch, KL, et al. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med 107 (2013), 249–255.
    • (2013) Respir Med , vol.107 , pp. 249-255
    • Lee, J.S.1    Kim, E.J.2    Lynch, K.L.3
  • 25
    • 84964010222 scopus 로고    scopus 로고
    • Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
    • 25 Collins, B, Raghu, G, Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur Respir J 47 (2016), 1293–1295.
    • (2016) Eur Respir J , vol.47 , pp. 1293-1295
    • Collins, B.1    Raghu, G.2
  • 26
    • 84865295963 scopus 로고    scopus 로고
    • Hypersensitivity pneumonitis: insights in diagnosis and pathobiology
    • 26 Selman, M, Pardo, A, King, TE Jr, Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 186 (2012), 314–324.
    • (2012) Am J Respir Crit Care Med , vol.186 , pp. 314-324
    • Selman, M.1    Pardo, A.2    King, T.E.3
  • 27
    • 84960080689 scopus 로고    scopus 로고
    • Hypersensitivity pneumonitis and antigen identification—an alternate approach
    • 27 Millerick-May, ML, Mulks, MH, Gerlach, J, et al. Hypersensitivity pneumonitis and antigen identification—an alternate approach. Respir Med 112 (2016), 97–105.
    • (2016) Respir Med , vol.112 , pp. 97-105
    • Millerick-May, M.L.1    Mulks, M.H.2    Gerlach, J.3
  • 28
    • 84860621394 scopus 로고    scopus 로고
    • An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease
    • 28 Meyer, KC, Raghu, G, Baughman, RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185 (2012), 1004–1014.
    • (2012) Am J Respir Crit Care Med , vol.185 , pp. 1004-1014
    • Meyer, K.C.1    Raghu, G.2    Baughman, R.P.3
  • 29
    • 84916207141 scopus 로고    scopus 로고
    • Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis
    • 29 Munoz, X, Sanchez-Ortiz, M, Torres, F, Villar, A, Morell, F, Cruz, MJ, Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis. Eur Respir J 44 (2014), 1658–1665.
    • (2014) Eur Respir J , vol.44 , pp. 1658-1665
    • Munoz, X.1    Sanchez-Ortiz, M.2    Torres, F.3    Villar, A.4    Morell, F.5    Cruz, M.J.6
  • 30
    • 80053091084 scopus 로고    scopus 로고
    • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
    • 30 Richeldi, L, Costabel, U, Selman, M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365 (2011), 1079–1087.
    • (2011) N Engl J Med , vol.365 , pp. 1079-1087
    • Richeldi, L.1    Costabel, U.2    Selman, M.3
  • 31
    • 84879323836 scopus 로고    scopus 로고
    • UIP diagnosed at surgical lung biopsy, 2000–2009: HRCT patterns and proposed classification system
    • 31 Gruden, JF, Panse, PM, Leslie, KO, Tazelaar, HD, Colby, TV, UIP diagnosed at surgical lung biopsy, 2000–2009: HRCT patterns and proposed classification system. AJR Am J Roentgenol 200 (2013), W458–W467.
    • (2013) AJR Am J Roentgenol , vol.200 , pp. W458-W467
    • Gruden, J.F.1    Panse, P.M.2    Leslie, K.O.3    Tazelaar, H.D.4    Colby, T.V.5
  • 32
    • 84897957320 scopus 로고    scopus 로고
    • Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
    • 32 Raghu, G, Lynch, D, Godwin, JD, et al. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. Lancet Respir Med 2 (2014), 277–284.
    • (2014) Lancet Respir Med , vol.2 , pp. 277-284
    • Raghu, G.1    Lynch, D.2    Godwin, J.D.3
  • 33
    • 84923857384 scopus 로고    scopus 로고
    • CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis
    • 33 Chung, JH, Chawla, A, Peljto, AL, et al. CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. Chest 147 (2015), 450–459.
    • (2015) Chest , vol.147 , pp. 450-459
    • Chung, J.H.1    Chawla, A.2    Peljto, A.L.3
  • 34
    • 84901810710 scopus 로고    scopus 로고
    • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
    • 34 Richeldi, L, du Bois, RM, Raghu, G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2071–2082.
    • (2014) N Engl J Med , vol.370 , pp. 2071-2082
    • Richeldi, L.1    du Bois, R.M.2    Raghu, G.3
  • 35
    • 84895446095 scopus 로고    scopus 로고
    • Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment
    • 35 Cottin, V, Richeldi, L, Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment. Eur Respir Rev 23 (2014), 106–110.
    • (2014) Eur Respir Rev , vol.23 , pp. 106-110
    • Cottin, V.1    Richeldi, L.2
  • 36
    • 85008698220 scopus 로고    scopus 로고
    • Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria
    • published online June 22.
    • 36 Raghu, G, Wells, AU, Nicholson, AG, et al. Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am J Respir Crit Care Med, 2016, 10.1164/rccm.201602-0402OC published online June 22.
    • (2016) Am J Respir Crit Care Med
    • Raghu, G.1    Wells, A.U.2    Nicholson, A.G.3
  • 37
    • 84880690413 scopus 로고    scopus 로고
    • Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
    • 37 Jin, GY, Lynch, D, Chawla, A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 268 (2013), 563–571.
    • (2013) Radiology , vol.268 , pp. 563-571
    • Jin, G.Y.1    Lynch, D.2    Chawla, A.3
  • 38
    • 84958719073 scopus 로고    scopus 로고
    • Association between interstitial lung abnormalities and all-cause mortality
    • 38 Putman, RK, Hatabu, H, Araki, T, et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA 315 (2016), 672–681.
    • (2016) JAMA , vol.315 , pp. 672-681
    • Putman, R.K.1    Hatabu, H.2    Araki, T.3
  • 39
    • 85007436470 scopus 로고    scopus 로고
    • Development and progression of interstitial lung abnormalities in the Framingham Heart Study
    • published online June 17.
    • 39 Akari, T, Putman, RK, Hatabu, H, et al. Development and progression of interstitial lung abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med, 2016, 10.1164/rccm.201512-2523OC published online June 17.
    • (2016) Am J Respir Crit Care Med
    • Akari, T.1    Putman, R.K.2    Hatabu, H.3
  • 41
    • 34247126863 scopus 로고    scopus 로고
    • Age, Gene/Environment Susceptibility–Reykjavik Study: multidisciplinary applied phenomics
    • 41 Harris, TB, Launer, LJ, Eiriksdottir, G, et al. Age, Gene/Environment Susceptibility–Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 165 (2007), 1076–1087.
    • (2007) Am J Epidemiol , vol.165 , pp. 1076-1087
    • Harris, T.B.1    Launer, L.J.2    Eiriksdottir, G.3
  • 42
    • 77949363490 scopus 로고    scopus 로고
    • Genetic epidemiology of COPD (COPDGene) study design
    • 42 Regan, EA, Hokanson, JE, Murphy, JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7 (2010), 32–43.
    • (2010) COPD , vol.7 , pp. 32-43
    • Regan, E.A.1    Hokanson, J.E.2    Murphy, J.R.3
  • 43
    • 42949146028 scopus 로고    scopus 로고
    • Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
    • 43 Vestbo, J, Anderson, W, Coxson, HO, et al., on behalf of the ECLIPSE investigators. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 31 (2008), 869–873.
    • (2008) Eur Respir J , vol.31 , pp. 869-873
    • Vestbo, J.1    Anderson, W.2    Coxson, H.O.3
  • 45
    • 84874338694 scopus 로고    scopus 로고
    • Interobserver variability in the CT assessment of honeycombing in the lungs
    • 45 Watadani, T, Sakai, F, Johkoh, T, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 266 (2013), 936–944.
    • (2013) Radiology , vol.266 , pp. 936-944
    • Watadani, T.1    Sakai, F.2    Johkoh, T.3
  • 46
    • 84883051839 scopus 로고    scopus 로고
    • The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)—practical implications
    • 46 Wells, AU, The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)—practical implications. Respir Res, 14(suppl 1), 2013, S2.
    • (2013) Respir Res , vol.14 , pp. S2
    • Wells, A.U.1
  • 47
    • 84979695447 scopus 로고    scopus 로고
    • In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011
    • 47 Hutchinson, JP, Fogarty, AW, McKeever, TM, Hubbard, RB, In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med 193 (2016), 1161–1167.
    • (2016) Am J Respir Crit Care Med , vol.193 , pp. 1161-1167
    • Hutchinson, J.P.1    Fogarty, A.W.2    McKeever, T.M.3    Hubbard, R.B.4
  • 48
    • 84988966334 scopus 로고    scopus 로고
    • Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report
    • 48 Collard, HR, Ryerson, CJ, Corte, TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report. Am J Respir Crit Care Med 194 (2016), 265–275.
    • (2016) Am J Respir Crit Care Med , vol.194 , pp. 265-275
    • Collard, H.R.1    Ryerson, C.J.2    Corte, T.J.3
  • 49
    • 84881669432 scopus 로고    scopus 로고
    • An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
    • 49 Travis, WD, Costabel, U, Hansell, DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 (2013), 733–748.
    • (2013) Am J Respir Crit Care Med , vol.188 , pp. 733-748
    • Travis, W.D.1    Costabel, U.2    Hansell, D.M.3
  • 50
    • 0033763063 scopus 로고    scopus 로고
    • A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease
    • 50 Miller, JD, Urschel, JD, Cox, G, et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg 70 (2000), 1647–1650.
    • (2000) Ann Thorac Surg , vol.70 , pp. 1647-1650
    • Miller, J.D.1    Urschel, J.D.2    Cox, G.3
  • 51
    • 48949091397 scopus 로고    scopus 로고
    • Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases
    • 51 Katzenstein, AL, Mukhopadhyay, S, Myers, JL, Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 39 (2008), 1275–1294.
    • (2008) Hum Pathol , vol.39 , pp. 1275-1294
    • Katzenstein, A.L.1    Mukhopadhyay, S.2    Myers, J.L.3
  • 52
    • 0035508478 scopus 로고    scopus 로고
    • Histopathologic variability in usual and nonspecific interstitial pneumonias
    • 52 Flaherty, KR, Travis, WD, Colby, TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 (2001), 1722–1727.
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 1722-1727
    • Flaherty, K.R.1    Travis, W.D.2    Colby, T.V.3
  • 53
    • 33845982186 scopus 로고    scopus 로고
    • Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis
    • 53 Collard, HR, Cool, CD, Leslie, KO, Curran-Everett, D, Groshong, S, Brown, KK, Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis. Histopathology 50 (2007), 258–265.
    • (2007) Histopathology , vol.50 , pp. 258-265
    • Collard, H.R.1    Cool, C.D.2    Leslie, K.O.3    Curran-Everett, D.4    Groshong, S.5    Brown, K.K.6
  • 54
    • 0038628915 scopus 로고    scopus 로고
    • Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease
    • 54 Flaherty, KR, Colby, TV, Travis, WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167 (2003), 1410–1415.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 1410-1415
    • Flaherty, K.R.1    Colby, T.V.2    Travis, W.D.3
  • 55
  • 56
    • 0035883582 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality
    • 56 King, TE Jr, Schwarz, MI, Brown, K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164 (2001), 1025–1032.
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 1025-1032
    • King, T.E.1    Schwarz, M.I.2    Brown, K.3
  • 57
    • 43049110169 scopus 로고    scopus 로고
    • Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome
    • 57 Hanak, V, Ryu, JH, de Carvalho, E, et al. Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. Respir Med 102 (2008), 852–856.
    • (2008) Respir Med , vol.102 , pp. 852-856
    • Hanak, V.1    Ryu, J.H.2    de Carvalho, E.3
  • 59
    • 66249145452 scopus 로고    scopus 로고
    • Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis
    • 59 Ohshimo, S, Bonella, F, Cui, A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179 (2009), 1043–1047.
    • (2009) Am J Respir Crit Care Med , vol.179 , pp. 1043-1047
    • Ohshimo, S.1    Bonella, F.2    Cui, A.3
  • 60
    • 33847664321 scopus 로고    scopus 로고
    • Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease
    • 60 Leslie, KO, Gruden, JF, Parish, JM, Scholand, MB, Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131 (2007), 407–423.
    • (2007) Arch Pathol Lab Med , vol.131 , pp. 407-423
    • Leslie, K.O.1    Gruden, J.F.2    Parish, J.M.3    Scholand, M.B.4
  • 61
    • 33646468631 scopus 로고    scopus 로고
    • Transbronchial biopsy in usual interstitial pneumonia
    • 61 Berbescu, EA, Katzenstein, AL, Snow, JL, Zisman, DA, Transbronchial biopsy in usual interstitial pneumonia. Chest 129 (2006), 1126–1131.
    • (2006) Chest , vol.129 , pp. 1126-1131
    • Berbescu, E.A.1    Katzenstein, A.L.2    Snow, J.L.3    Zisman, D.A.4
  • 62
    • 77951918393 scopus 로고    scopus 로고
    • Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia
    • 62 Shim, HS, Park, MS, Park, IK, Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int 60 (2010), 373–377.
    • (2010) Pathol Int , vol.60 , pp. 373-377
    • Shim, H.S.1    Park, M.S.2    Park, I.K.3
  • 63
    • 84930871576 scopus 로고    scopus 로고
    • Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data
    • 63 Kim, SY, Diggans, J, Pankratz, D, et al. Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data. Lancet Respir Med 3 (2015), 473–482.
    • (2015) Lancet Respir Med , vol.3 , pp. 473-482
    • Kim, S.Y.1    Diggans, J.2    Pankratz, D.3
  • 64
    • 85020374483 scopus 로고    scopus 로고
    • Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis
    • published online Aug 13.
    • 64 Sharp, C, McCabe, M, Adamali, H, Medford, AR, Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis. QJM, 2016, 10.1093/qjmed/hcw142 published online Aug 13.
    • (2016) QJM
    • Sharp, C.1    McCabe, M.2    Adamali, H.3    Medford, A.R.4
  • 65
    • 84896514009 scopus 로고    scopus 로고
    • Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases
    • 65 Casoni, GL, Tomassetti, S, Cavazza, A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One, 9, 2014, e86716.
    • (2014) PLoS One , vol.9 , pp. e86716
    • Casoni, G.L.1    Tomassetti, S.2    Cavazza, A.3
  • 66
    • 84982170094 scopus 로고    scopus 로고
    • Cryobiopsy in the diagnosis of interstitial lung disease. A step forward or back?
    • 66 Patel, NM, Borczuk, AC, Lederer, DJ, Cryobiopsy in the diagnosis of interstitial lung disease. A step forward or back?. Am J Respir Crit Care Med 193 (2016), 707–709.
    • (2016) Am J Respir Crit Care Med , vol.193 , pp. 707-709
    • Patel, N.M.1    Borczuk, A.C.2    Lederer, D.J.3
  • 67
    • 0037080547 scopus 로고    scopus 로고
    • American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
    • 67 American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 (2002), 277–304.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 277-304
  • 68
    • 5144222998 scopus 로고    scopus 로고
    • Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
    • 68 Flaherty, KR, King, TE Jr, Raghu, G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 170 (2004), 904–910.
    • (2004) Am J Respir Crit Care Med , vol.170 , pp. 904-910
    • Flaherty, K.R.1    King, T.E.2    Raghu, G.3
  • 69
    • 34248372493 scopus 로고    scopus 로고
    • Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?
    • 69 Flaherty, KR, Andrei, AC, King, TE Jr, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?. Am J Respir Crit Care Med 175 (2007), 1054–1060.
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 1054-1060
    • Flaherty, K.R.1    Andrei, A.C.2    King, T.E.3
  • 70
    • 84981351583 scopus 로고    scopus 로고
    • Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
    • 70 Tomassetti, S, Wells, AU, Costabel, U, et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193 (2016), 745–752.
    • (2016) Am J Respir Crit Care Med , vol.193 , pp. 745-752
    • Tomassetti, S.1    Wells, A.U.2    Costabel, U.3
  • 71
    • 84951570581 scopus 로고    scopus 로고
    • Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment
    • 71 Tominaga, J, Sakai, F, Johkoh, T, et al. Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment. Eur J Radiol 84 (2015), 2640–2645.
    • (2015) Eur J Radiol , vol.84 , pp. 2640-2645
    • Tominaga, J.1    Sakai, F.2    Johkoh, T.3
  • 72
    • 84901754507 scopus 로고    scopus 로고
    • Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
    • 72 Cottin, V, Crestani, B, Valeyre, D, et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines. Eur Respir Rev 23 (2014), 193–214.
    • (2014) Eur Respir Rev , vol.23 , pp. 193-214
    • Cottin, V.1    Crestani, B.2    Valeyre, D.3
  • 73
    • 84900328026 scopus 로고    scopus 로고
    • Genetic determinants of pulmonary fibrosis: evolving concepts
    • 73 Spagnolo, P, Grunewald, J, du Bois, RM, Genetic determinants of pulmonary fibrosis: evolving concepts. Lancet Respir Med 2 (2014), 416–428.
    • (2014) Lancet Respir Med , vol.2 , pp. 416-428
    • Spagnolo, P.1    Grunewald, J.2    du Bois, R.M.3
  • 74
  • 75
    • 84901020197 scopus 로고    scopus 로고
    • Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute
    • 75 Thannickal, VJ, Henke, CA, Horowitz, JC, et al. Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. Am J Pathol 184 (2014), 1643–1651.
    • (2014) Am J Pathol , vol.184 , pp. 1643-1651
    • Thannickal, V.J.1    Henke, C.A.2    Horowitz, J.C.3
  • 78
    • 43249084804 scopus 로고    scopus 로고
    • MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
    • 78 Rosas, IO, Richards, TJ, Konishi, K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med, 5, 2008, e93.
    • (2008) PLoS Med , vol.5 , pp. e93
    • Rosas, I.O.1    Richards, T.J.2    Konishi, K.3
  • 79
    • 84922948913 scopus 로고    scopus 로고
    • Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease
    • 79 Kropski, JA, Pritchett, JM, Zoz, DF, et al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am J Respir Crit Care Med 191 (2015), 417–426.
    • (2015) Am J Respir Crit Care Med , vol.191 , pp. 417-426
    • Kropski, J.A.1    Pritchett, J.M.2    Zoz, D.F.3
  • 80
    • 84930865108 scopus 로고    scopus 로고
    • Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
    • 80 Jenkins, RG, Simpson, JK, Saini, G, et al. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study. Lancet Respir Med 3 (2015), 462–472.
    • (2015) Lancet Respir Med , vol.3 , pp. 462-472
    • Jenkins, R.G.1    Simpson, J.K.2    Saini, G.3
  • 81
    • 84866723961 scopus 로고    scopus 로고
    • Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis
    • 81 Leeming, DJ, Sand, JM, Nielsen, MJ, et al. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark Insights 7 (2012), 119–126.
    • (2012) Biomark Insights , vol.7 , pp. 119-126
    • Leeming, D.J.1    Sand, J.M.2    Nielsen, M.J.3
  • 82
    • 84858427847 scopus 로고    scopus 로고
    • Peripheral blood biomarkers in idiopathic pulmonary fibrosis
    • 82 Vij, R, Noth, I, Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl Res 159 (2012), 218–227.
    • (2012) Transl Res , vol.159 , pp. 218-227
    • Vij, R.1    Noth, I.2
  • 83
    • 84998814253 scopus 로고    scopus 로고
    • Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias
    • published online May 5.
    • 83 White, ES, Xia, M, Murray, S, et al. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2016, 10.1164/rccm.201505-0862OC published online May 5.
    • (2016) Am J Respir Crit Care Med
    • White, E.S.1    Xia, M.2    Murray, S.3
  • 84
    • 84925086698 scopus 로고    scopus 로고
    • Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression
    • 84 Yang, G, Yang, L, Wang, W, Wang, J, Wang, J, Xu, Z, Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Gene 562 (2015), 138–144.
    • (2015) Gene , vol.562 , pp. 138-144
    • Yang, G.1    Yang, L.2    Wang, W.3    Wang, J.4    Wang, J.5    Xu, Z.6
  • 85
    • 84862677507 scopus 로고    scopus 로고
    • The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis
    • 85 Yang, IV, Luna, LG, Cotter, J, et al. The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. PLoS One, 7, 2012, e37708.
    • (2012) PLoS One , vol.7 , pp. e37708
    • Yang, I.V.1    Luna, L.G.2    Cotter, J.3
  • 86
    • 84857922118 scopus 로고    scopus 로고
    • S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
    • 86 Hara, A, Sakamoto, N, Ishimatsu, Y, et al. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Respir Med 106 (2012), 571–580.
    • (2012) Respir Med , vol.106 , pp. 571-580
    • Hara, A.1    Sakamoto, N.2    Ishimatsu, Y.3
  • 87
    • 84883053337 scopus 로고    scopus 로고
    • CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases
    • 87 Cai, M, Bonella, F, He, X, et al. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Respir Med 107 (2013), 1444–1452.
    • (2013) Respir Med , vol.107 , pp. 1444-1452
    • Cai, M.1    Bonella, F.2    He, X.3
  • 88
    • 84922227403 scopus 로고    scopus 로고
    • A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis
    • 88 Bauer, Y, Tedrow, J, de Bernard, S, et al. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 52 (2015), 217–231.
    • (2015) Am J Respir Cell Mol Biol , vol.52 , pp. 217-231
    • Bauer, Y.1    Tedrow, J.2    de Bernard, S.3
  • 89
    • 80053472343 scopus 로고    scopus 로고
    • Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle
    • 89 Meltzer, EB, Barry, WT, D'Amico, TA, et al. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics, 4, 2011, 70.
    • (2011) BMC Med Genomics , vol.4 , pp. 70
    • Meltzer, E.B.1    Barry, W.T.2    D'Amico, T.A.3
  • 90
    • 31944436620 scopus 로고    scopus 로고
    • Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis
    • 90 Selman, M, Pardo, A, Barrera, L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 173 (2006), 188–198.
    • (2006) Am J Respir Crit Care Med , vol.173 , pp. 188-198
    • Selman, M.1    Pardo, A.2    Barrera, L.3
  • 91
    • 84919768376 scopus 로고    scopus 로고
    • Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
    • 91 DePianto, DJ, Chandriani, S, Abbas, AR, et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70 (2015), 48–56.
    • (2015) Thorax , vol.70 , pp. 48-56
    • DePianto, D.J.1    Chandriani, S.2    Abbas, A.R.3
  • 92
    • 84881157502 scopus 로고    scopus 로고
    • Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature
    • 92 Hodnett, PA, Naidich, DP, Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. Am J Respir Crit Care Med 188 (2013), 141–149.
    • (2013) Am J Respir Crit Care Med , vol.188 , pp. 141-149
    • Hodnett, P.A.1    Naidich, D.P.2
  • 93
    • 84901759236 scopus 로고    scopus 로고
    • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
    • 93 King, TE Jr, Bradford, WZ, Castro-Bernardini, S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2083–2092.
    • (2014) N Engl J Med , vol.370 , pp. 2083-2092
    • King, T.E.1    Bradford, W.Z.2    Castro-Bernardini, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.